ePlus: The Growth Machine Keeps Running, But The Cash Keeps Waiting

ePlus reported Q3 FY26 sales up 24.6% YoY driven by strong AI-related demand. Management raised FY26 guidance to 20–22% net sales growth and adjusted EBITDA up 41–43%, indicating sustained momentum. However, inventory doubled to $241M and operating cash flow remained negative, highlighting persistent working-capital pressure despite strong earnings.

Analysis

Management has bought time on growth with a clear AI demand narrative, but the economics show a classic growth-with-working-capital trap: margins expand on booked revenue while cash conversion slips as inventory and receivables outpace sales. That dynamic can inflate near-term adjusted EBITDA without creating free cash flow, leaving liquidity to be managed through credit lines, supplier terms, or slower vendor payment — each with its own P&L and covenant consequences over the next 2–6 quarters.

Second-order winners include high-turn distributors and component suppliers who can offer pull-through financing or drop-ship models; conversely, competitors with leaner supply chains can win fines-of-business if PLUS has to clear channel inventory or offer aggressive pricing. Banks and specialty finance providers stand to earn fees if management levers receivables or inventory financing, and any failure to normalize working capital would tilt negotiation leverage toward those lenders within a 3–12 month window.

Tail risks cluster around a liquidity squeeze and demand re-pricing: a slower-than-expected cadence of AI deployments or a step-up in warranty/returns could force inventory markdowns and reverse margin leverage within a quarter. The simplest path to sustained re-rating is conversion of that inventory into cash within 1–2 quarters or credible disclosure of a non-dilutive financing solution; absent those, downside could be 30–50% of the current equity re-rating as multiples reprice to cash-flow reality.

For portfolio construction, treat exposure as event-driven, not pure secular AI exposure. The asymmetric payoff is real — upside from continued AI penetration plus re-rating if cash conversion normalizes, offset by concentrated operational execution and liquidity risk that can materialize quickly — position sizes should be sized accordingly and hedged through put protection or relative-value pairs over the next 6–12 months.

Key Decisions for Investors

• PLUS — Tactical long (6–12 months): buy the equity at a modest position size (max 1.5% NAV) and purchase 6–9 month protective puts (50–70% deltas) to cap downside; R/R: capture re-rate if OCF normalizes while limiting drawdown from working-capital shock.
• PLUS — Event option spread (9–12 months): buy longer-dated call spread (buy 12-month ATM call, sell 12-month 1.5x strike) financed by selling 3–4 month OTM calls to collect premium; R/R: ~2–3x upside if company converts inventory to cash or sustains AI bookings, limited cost if near-term volatility subsides.
• Relative trade — Long PLUS / Short large-cap reseller (e.g., CDW) — 3–6 months: size neutral dollar exposure to isolate working-capital execution vs secular reseller demand; R/R: positive if PLUS converts inventory and re-rates, or negative if PLUS cash conversion lags and reseller holds steadier margins.
• Credit/flow trade — Monitor for receivables-backed financing: commit to short-dated credit exposure (commercial paper or structured note) if a secured receivables facility is announced; R/R: capture elevated financing spreads (low-duration yield pickup) while downside limited by collateral structure — execute within 30 days of announcement.